
International Flavors & Fragrances, Inc.
IFF·NYSE
Last updated as of 2026-03-09 18:44 EST. Stock price information is sourced from TradingView and reflects real-time market prices.
Insights
Calculator
News
IFF stock price change
On the last trading day, IFF stock closed at 72.00 USD, with a price change of -2.40% for the day.
Trade stock perpsTrending stocks
About Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn moreIFF key data
Previous close72.00 USD
Market cap18.39B USD
Volume507.75K
P/E ratio-
Dividend yield (TTM)2.12%
Dividend amount0.40 USD
Last ex-dividend dateDec 19, 2025
Last payment dateJan 09, 2026
EPS diluted (TTM)-1.37 USD
Net income (FY)−374.00M USD
Revenue (FY)10.89B USD
Next report dateMay 11, 2026
EPS estimate1.080 USD
Revenue estimate2.65B USD USD
Shares float251.45M
Beta (1Y)0.58

International Flavors & Fragrances, Inc. overview
International Flavors & Fragrances, Inc. engages in the manufacture and supply of flavors and fragrances used in the food, beverage, personal care, and household products industries. It operates through the following segments: Nourish, Health & Biosciences, Scent and Pharma Solutions. The Nourish segment consists of legacy Taste segment combined with N&B's Food & Beverage division and the food protection business of N&B's Health & Biosciences division. The Health & Biosciences business consists of a biotechnology-driven portfolio of enzymes, food cultures, probiotics and specialty ingredients for food, home and personal care, and health and wellness applications. The Scent business creates fragrance compounds, fragrance ingredients and cosmetic ingredients that are integral elements in the world’s finest perfumes and best-known household and personal care products. The Pharma Solutions business produces a vast portfolio including cellulosics and seaweed-based pharma excipients, used to improve the functionality and delivery of active pharmaceutical ingredients, including controlled or modified drug release formulations, and enabling. The company was founded in 1833 and is headquartered in New York, NY.
Sector
Consumer non-durables
Industry
Food: Specialty/Candy
CEO
Jon Erik Fyrwald
Headquarters
New York
Website
iff.com
Founded
1833
Employees (FY)
-
Change (1Y)
-
Revenue / Employee (1Y)
-
Net income / Employee (1Y)
-
IFF Pulse
Daily updates on IFF stock prices, fund flows, and market news, generated by AI and reviewed by our team of analysts. Always DYOR.
See more
about 6h ago
See more
about 1D ago
IFF stock price forecast
According to technical indicators for IFF stock, the price is likely to fluctuate within the range of 82.38–86.28 USD over the next week. Market analysts predict that the price of IFF stock will likely fluctuate within the range of 65.57–110.97 USD over the next months.
Based on 1-year price forecasts from 52 analysts, the highest estimate is 129.20 USD, while the lowest estimate is 89.34 USD.
For more information, please see the
IFF stock price forecast
page.
Latest IFF stock news
Frequency Electronics Announces Third Quarter Fiscal 2026 Financial Results Conference Call: Wednesday, March 11, 2026, at 4:30 PM ET
Finviz2026-03-09 20:06:47
Ardelyx Announces Publication of a Review Article Demonstrating Rapid and Meaningful Symptom Relief with Tenapanor in IBS-C
Finviz2026-03-09 20:06:47
AEON Biopharma Appoints John Bencich as Chief Financial Officer
Finviz2026-03-09 20:09:52
GEE Group Inc. Director Bill Isaac Retires from the Board
Finviz2026-03-09 20:37:27
On March 9, 2026, CACI International officially signed the first amendment to the Class B Term Loan Agreement.
老虎证券2026-03-09 20:54:43
SAB BIO Reports Full Year 2025 Financial Results and Business Highlights
Finviz2026-03-09 21:21:47
Billionaire John Paulson Owns Nearly Half This Gold Miner - Despite Zero Gold Output
Finviz2026-03-09 21:24:47
Robinhood Markets, Inc. (HOOD) Aims to Become a "Financial Super App" with 20%+ Growth
Finviz2026-03-09 21:30:48
Celcuity Announces Publication of Results from PIK3CA Wild-Type Cohort of Phase 3 VIKTORIA-1 Study of Gedatolisib Regimens in HR+/HER2- Advanced Breast Cancer in Journal of Clinical Oncology
Finviz2026-03-09 21:45:39
Not So Boring: Elon Musk's Las Vegas Tunnel Helps 82,000 Passengers During Construction Expo
Finviz2026-03-09 21:54:49
Top Equity Analyses for Visa, Chevron & Toyota Motor
101 finance2026-03-09 22:09:42
Amazon Rises 0.13% with $11.38B in Volume as Brazil's Amazon Fuels Seventh-Highest Trading Day
101 finance2026-03-09 22:22:06
Spotting Top Performers: Mister Car Wash (NASDAQ:MCW) and Specialized Consumer Services Stocks in the Consumer Discretionary Sector for Q4
101 finance2026-03-09 22:27:32
AAL's 2.33% Surge Driven by $1B Miami Expansion as Stock Ranks 67th in Daily Trading Volume
101 finance2026-03-09 22:39:39
Modern Quick-Service Restaurant Stocks Q4 Analysis: Wingstop (NASDAQ:WING) Compared to Competitors
101 finance2026-03-09 22:42:44
Frequency Electronics Announces Third Quarter Fiscal 2026 Financial Results Conference Call: Wednesday, March 11, 2026, at 4:30 PM ET
Finviz2026-03-09 20:06:47
Ardelyx Announces Publication of a Review Article Demonstrating Rapid and Meaningful Symptom Relief with Tenapanor in IBS-C
Finviz2026-03-09 20:06:47
AEON Biopharma Appoints John Bencich as Chief Financial Officer
Finviz2026-03-09 20:09:52
GEE Group Inc. Director Bill Isaac Retires from the Board
Finviz2026-03-09 20:37:27
On March 9, 2026, CACI International officially signed the first amendment to the Class B Term Loan Agreement.
老虎证券2026-03-09 20:54:43
SAB BIO Reports Full Year 2025 Financial Results and Business Highlights
Finviz2026-03-09 21:21:47



